What we do Maitreya Medicare Ltd provides advanced inpatient and outpatient healthcare services through hospitals across Gujarat and Maharashtra with specialties including cardiology, neurology, oncology, and surgery. |
Founded in 2,019 |
Market share Emerging healthcare services provider with expanding hospital network and 550 beds aggregate capacity. |
Problem solved Accessible, advanced, affordable healthcare treatments across multiple specialties to meet growing patient needs in Western India. |
Top clients or who we serve Hospital patients across Gujarat and Maharashtra, serving urban and semi-urban populations through B2C healthcare services. |
Key management Dr. Narendra Singh Tanwar, Chairman & Managing Director, an eminent cardiologist with 20+ years of healthcare experience. |
Our journey and innovations Started in 2019, expanded Surat hospital beds from 100 to 125, launched IPO in 2023 raising Rs 14.89 crores, initiating new hospital in Valsad. |
Where we operate Hospitals in Surat, Mumbai, Valsad, and Nandurbar in India, with plans to expand beds and specialties. |
Top products or what we offer Inpatient and outpatient healthcare services including cardiology, neurology, oncology, nephrology, surgeries, ICU, and dialysis. |
Top brands Maitreya Hospitals - known for advanced Cathlab, modular operation theatres with HEPA filters, and intensive care units. |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mainly recurring from healthcare services and hospital operations. |
Our industry position Growing healthcare services provider in Western India with strong medical expertise and expanding facilities. |
Financial highlights Standalone revenue Rs 465 crore with net profit of Rs 31.7 crore for FY24; consolidated revenue Rs 478 crore with net profit Rs 27.6 crore. |
Geographical revenue split Revenue primarily from Gujarat and Maharashtra regions in India. |
Order book - |
Whats driving growth Hospital bed expansions, specialty services additions, IPO capital infusion, and increased patient demand. |
Our future plans Expanding Valsad hospital to 125 beds, potential 75-bed expansion in Surat for advanced quaternary care including organ transplants and robotics. |
Our green promise - |
Our people and values Experienced medical staff including doctors, nurses, pharmacists, and support teams dedicated to quality patient care. |
Key challenges ahead Scaling infrastructure while maintaining quality, competitive healthcare market, and regulatory compliance. |
Interesting facts Commissioned Surat hospital in 2019, quickly expanded beds and specialties; IPO oversubscribed in 2023. |
Risks and strategy Address risks through strong governance, experienced leadership, and focused investment in specialized care. |
